Retatrutide at the 12 mg dose with 24.2% over 48 weeks (TRIUMPH-1, NEJM 2023), followed by tirzepatide at 15 mg with 20.9% over 72 weeks (SURMOUNT-1), then semaglutide at 2.4 mg with 14.9% over 68 weeks (STEP-1)
THCV's interaction with cannabinoid receptors appears to support these processes naturally, potentially offering metabolic benefits without the digestive disruption
Thats why our program focuses on whole-person metabolic care , not just the number on the scale
Week 4+: With consistent twice-daily use + sun protection, achieve lasting clarity, even tone, improved firmness, and confident bare-skin radiance on body
actual product may vary Compounded Semaglutide contains the same active ingredient as Ozempic and Wegovy and is prescribed for type 2 diabetes or off-label for weight loss